Blood test vs. needle biopsy: new hope for pancreatic cancer diagnosis?
NCT ID NCT02072616
First seen Feb 06, 2026 · Last updated May 13, 2026 · Updated 13 times
Summary
This study aimed to see if a blood test could detect pancreatic cancer by finding circulating tumor cells (CTCs) or tumor DNA, potentially avoiding the need for invasive biopsies. Researchers planned to compare the blood test results with standard tissue sampling in 101 adults with non-metastatic pancreatic tumors. The study was terminated early, so its final conclusions are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UH Rouen
Rouen, 76031, France
Conditions
Explore the condition pages connected to this study.